Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
Small cell lung cancer cells (SCLC) are differentially sensitive to inhibitors of the BCL-2 family. Here the authors analyse the response to BH3 mimetics in SCLC, delineate patterns of expression of apoptotic proteins correlated with differential sensitivities and demonstrate a synergistic anti-tumo...
Guardado en:
Autores principales: | Akane Inoue-Yamauchi, Paul S. Jeng, Kwanghee Kim, Hui-Chen Chen, Song Han, Yogesh Tengarai Ganesan, Kota Ishizawa, Sylvia Jebiwott, Yiyu Dong, Maria C. Pietanza, Matthew D. Hellmann, Mark G. Kris, James J. Hsieh, Emily H. Cheng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5d834b769b2400b86f4baf0dda324e5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Two independent positive feedbacks and bistability in the Bcl-2 apoptotic switch.
por: Jun Cui, et al.
Publicado: (2008) -
Mito-priming as a method to engineer Bcl-2 addiction
por: Jonathan Lopez, et al.
Publicado: (2016) -
Bcl-xL promotes metastasis independent of its anti-apoptotic activity
por: Soyoung Choi, et al.
Publicado: (2016) -
UBQLN4 is an ATM substrate that stabilizes the anti‐apoptotic proteins BCL2A1 and BCL2L10 in mesothelioma
por: Fang Liu, et al.
Publicado: (2021) -
α7 nicotinic acetylcholine receptor upregulation by anti-apoptotic Bcl-2 proteins
por: G. Brent Dawe, et al.
Publicado: (2019)